Cambridge University to Use Affy, ParAllele Tech in Diabetes Genotyping Study | GenomeWeb

NEW YORK, July 20 (GenomeWeb News) - A team of researchers at Cambridge University will use technology from Affymetrix and ParAllele in a study that will eventually genotype 20,000 type 1 diabetes patients, the companies said today.

 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A Karmagenes researcher has lost his position after reportedly admitting to data fabrication, according to Retraction Watch.

Two neuroscientists write in Nature News that solving the "reproducibility crisis" in science may require changing the requirements for publication.

In Nature this week: genomic analysis of prehistoric New Mexicans, a nanopore method for mapping DNA methylation, and more.

A new study finds that adding missing good bacteria to the skin microbiome of atopic dermatitis patients decreases Staphylococcus aureus colonization.